Allan Lawrie

Agency for Science, Technology and Research — Singapore

Medicine · Health Sciences

60h-index11.1kcitations287works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(190), Cardiovascular Function and Risk Factors(30), MicroRNA in disease regulation(17), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(15), Bone health and treatments(15)

Publications266 total

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment
EBioMedicine·2025Open Access
Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis
European Heart Journal·2025
BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivity
Angiogenesis·2025Open Access
S143 StratosPHere 1 study – a novel BMP target engagement biomarker panel for use in clinical trials demonstrates sotatercept alters gene expression in PAH
2025
S146 Inflammation and obesity correlate in pulmonary hypertension but associate with diverging outcomes
2025
Prevalence of WHO Group 2 and 3 pulmonary hypertension in England 2005–2020: a population-based study
Epidemiology·2025
Inflammation and obesity correlate in pulmonary hypertension but associate with diverging outcomes
2025
Pulmonary Hypertension associated with Interstitial Lung Disease in the PVRI GoDeep Meta-Registry
2025
Late Breaking Abstract - StratosPHere 1 study - a novel BMP target engagement biomarker panel for use in clinical trials demonstrates sotatercept alters gene expression in pulmonary arterial hypertension
2025
Fine-tuning LLMs in behavioral psychology for scalable health coaching
npj Cardiovascular Health·2025· 1 citedOpen Access
Longitudinal Comorbidity Patterns Prior to Pulmonary Hypertension Diagnosis
2025Open Access
Inflammation and Obesity Correlate in Pulmonary Hypertension but Are Associated with Diverging Outcomes
American Journal of Respiratory and Critical Care Medicine·2025Open Access
Leptin and adiponectin in children and young persons with congenital adrenal hyperplasia
European Journal of Endocrinology·2025Open Access
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
American Journal of Respiratory and Critical Care Medicine·2025· 2 cited
Assessing pulmonary artery stiffening with ultrasonography: a step forward for the assessment of pulmonary hypertension due to left heart disease?
Cardiovascular Research·2025Open Access
<scp>NT</scp> ‐ <scp>proBNP</scp> and <scp>BNP</scp> Testing in Pulmonary Arterial Hypertension: Point‐of‐Care and Remote Monitoring
Respirology·2025· 1 citedOpen Access
Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta‐Registry
Pulmonary Circulation·2025· 2 citedOpen Access
Patient-specific modelling of pulmonary arterial hypertension: wall shear stress correlates with disease severity
Frontiers in Bioengineering and Biotechnology·2025Open Access
Clustering Patients with Pulmonary Hypertension Using the Plasma Proteome
American Journal of Respiratory and Critical Care Medicine·2025· 4 citedOpen Access
Male Survival Disadvantage in Pulmonary Hypertension in the PVRI Godeep Meta-registry
American Journal of Respiratory and Critical Care Medicine·2025
page 1 of 14Next →

Frequent Co-authors

David G. Kiely(21), Robin Condliffe(16), Martin R. Wilkins(11), John Wharton(10), Nicholas W. Morrell(10), Colin Church(9), Christopher J. Rhodes(9), Andrew J. Swift(9), Carmen Treacy(8), Barbara Girerd(8), Luke Howard(8), Marc Humbert(8), David Montani(8), Joanna Pepke‐Żaba(8), Anton Vonk Noordegraaf(8), A. A. Roger Thompson(8), Alexander Rothman(8), Jim M. Wild(7), Charaka Hadinnapola(7), Mark Toshner(7)